Search results for " mAbs"

Article What is process development?
What is process development? Biopharma process development comprises the activities that help you create a series of steps to produce a biomolecule – a monoclonal antibody (mAb), recomb…

Article Top Process Development Trends for 2022 and a Look into 2023
FDA approved 37 drugs in 2022, within the normal range for the past decade or so. The European Medicines Agency (EMA) was even more successful—approving a record 55 therapies. More than half of thes…

Article Establishing a Robust Workflow to Identify High-Performing GOCHO™ Clones
Our cell line development platform uses the GOCHO™ host cell line to minimize the risk and timeline to develop high-performing clones suitable for manufacturing. LEARN MORE >>

Article Sign-up to join Chromatography Virtual Summit 2022
Latest advancements in chromatography process development. Go smarter. Go faster. Virtual event 15–17 November 2022 Join the Cytiva chromatography summit online to l…

Article Approaches to scaling up Chromatography Processes
Scaling up chromatography resins requires a thorough understanding of their intended use. READ FULL ARTICLE >> 

Article Optimization of an antibody polishing step
Antibody purification processes are typically developed using a platform approach. Optimal operating conditions for single units are found by altering just a few process parameters with De…

Article Bispecific Antibodies are Moving from Research to Clinical Development
With recent approvals of bispecific antibodies, these complex molecules are fast moving out of the research box and into clinical pipelines. READ MORE >>

Article Navigating Molecular Diversity
Are you working with biomolecules beyond mAbs? Read more here >>

Article Getting Started with Fibro PrismA - Free e-Learning
Learn about Fibro PrismA >> Are you using resin-based columns? Fibro PrismA units for rapid cycling chromatography connect to ÄKTA™ systems in the same way. Additionally, you can use the s…

Article Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
This article will explore the traditional path from the laboratory to the clinic and how the fixed-bed technology provides an alternative solution to meet commercial demands. By Alex Chatel and …

Previous PageNext Page